Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care manufacturing...
A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all mothers following...
The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy.
Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind.
MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC)...
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs on Chinese imports.
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine as Lundbeck acquire Abide Therapeutics in deal worth $400 million....
The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall in the number of NHS GPs for more than...
Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell...
Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches